摘要
目的:探究甲状腺乳头癌患者手术后,接受^131I治疗后患者颈部的SPECT/CT显像价值。方法:在本院数据库中回顾性收集时间段2016年4月~2018年5月,本院中进行甲状腺全切术后,接受^131I治疗的患者61例作为研究对象,所有患者在治疗后6~7d内同时进行^131I治疗,并对患者进行颈部SPECT/CT断层融合现象分析差异。结果:在实验结果中显示^131I全身显像中患者可见放射性^131I浓聚灶54例,颈部SPECT/CT断层融合现象共发现59例^131I浓聚灶其中放射性^131I浓聚灶位于患者颈部正中,甲状腺中包括41例,经诊断确认这类患者为术后残留甲状腺。结论:在手术治疗甲状腺乳头状癌后,接受^131I治疗后,患者颈部的SPECT/CT断层融合,能够更优化的发现患者的不残留甲状腺状况同时对于患者的放射性^131I浓聚灶来说有较好的明确度。
Objective:To investigate the value of SPECT/CT imaging of patients with thyroid papillary carcinoma after surgery and^131 I.Methods:A retrospective collection period in our hospital database from April 2016 to May 2018 was performed in 61 patients who underwent^131 I treatment after total thyroidectomy in our hospital.All patients were treated after 6 months of treatment.^131 I treatment was performed at the same time within 7 days,and the patients were analyzed for differences in neck SPECT/CT tomography.Results:In the experimental results,54 cases of radioactive^131 I concentrated foci were seen in^131 I wholebody imaging,and 59 cases of^131 I concentrated foci were found in the neck SPECT/CT tomography.There were 41 cases of thyroid,which were diagnosed as residual thyroid after surgery.Conclusion:After surgical treatment of papillary thyroid carcinoma,after receiving^131 I treatment,the SPECT/CT tomography of the patient’s neck can better find the patient’s non-residual thyroid status and it is more effective for the patient’s radioactive^131 I concentrated focus.Good clarity is worth promoting.
作者
赵斌
ZHAO Bin(Panjin Liaoyou Baoshihua Hospital,Liaoning Panjin 124010)
出处
《中国医疗器械信息》
2020年第3期67-68,共2页
China Medical Device Information